New eye ointment tested for common eyelid condition
NCT ID NCT06400511
Summary
This study tested whether a medicated ointment called pimecrolimus could safely and effectively treat blepharitis, a common condition causing red, irritated, and crusty eyelids. Nearly 500 participants aged 2 and older applied the ointment or a placebo (inactive version) to their eyelids twice a day for 6 weeks. The goal was to see if the treatment could completely clear eyelid debris and reduce discomfort.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEPHARITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Investigative Site
Pheonix, Arizona, 85032, United States
-
Clinical Investigator Site
Garden Grove, California, 92843, United States
-
Clinical Investigator Site
Glendale, California, 91204, United States
-
Clinical Investigator Site
Inglewood, California, 90301, United States
-
Clinical Investigator Site
Newport Beach, California, 92663, United States
-
Clinical Investigator Site
Petaluma, California, 94954, United States
-
Clinical Investigator Site
Rancho Cordova, California, 95670, United States
-
Clinical Investigator Site
Aurora, Colorado, 80045, United States
-
Clinical Investigator Site
Crystal River, Florida, 34429, United States
-
Clinical Investigator Site
Largo, Florida, 33773, United States
-
Clinical Investigator Site
Tampa, Florida, 33603, United States
-
Clinical Investigator Site
Atlanta, Georgia, 30339, United States
-
Clinical Investigator Site
Morrow, Georgia, 30260, United States
-
Clinical Investigator Site
Pittsburg, Kansas, 66762, United States
-
Clinical Investigator Site
Louisville, Kentucky, 40206, United States
-
Clinical Investigator Site
Havre de Grace, Maryland, 21078, United States
-
Clinical Investigator Site
Medina, Minnesota, 55340, United States
-
Clinical Investigator Site
Kansas City, Missouri, 64154, United States
-
Clinical Investigator Site
Washington, Missouri, 63090, United States
-
Clinical Investigator Site
Garner, North Carolina, 27529, United States
-
Clinical Investigator Site
Cincinnati, Ohio, 45242, United States
-
Clinical Investigator Site
Cranberry Township, Pennsylvania, 16066, United States
-
Clinical Investigator Site
Smyrna, Tennessee, 37167, United States
-
Clinical Investigator Site
Austin, Texas, 78731, United States
-
Clinical Investigator Site
Lakeway, Texas, 78738, United States
-
Clinical Investigator Site
San Antonio, Texas, 78229, United States
-
Clinical Investigator Site
Clinton, Utah, 84015, United States
-
Clinical Investigator Site
Lynchburg, Virginia, 24502, United States
-
Investigative Site
St Louis, Missouri, 63131, United States
Conditions
Explore the condition pages connected to this study.